Kulkarni et al. demonstrated that growth hormone (GH) promotes drug resistance and migration in melanoma by enhancing the release of exosomes enriched with ABCC1, ABCB1, and other resistance-related proteins. The gene discussed is GH1; the disease is melanoma.